Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
First-Half Sales Performance in Line with Full-Year 2024 Guidance
vetmeduni Wien: Caripe 8: Wiener Forschungsteam identifiziert neuen Anti-Krebswirkstoff
Die Natur ist ein reicher Quell für medizinische Wirkstoffe. Ein großer Teil davon ist bislang aber unerforscht. Mit…
Hookipa Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
New Leadership Appointments; Positive Clinical and Regulatory Reports for the Lead Product Candidate, HB-200…
Evercyte P-EP/SVTERT344 telomerized amniotic epithelial cells from placenta
Evercyte has added P-EP/SVTERT344 telomerized amniotic epithelial cells to its range of immortalized cell lines.
BMSGPK: Novelle der Blutspenderverordnung erhöht Sicherheit für Spender:innen
Regeln an aktuellen Stand der Wissenschaft angepasst - erstmals Vorgaben für das dritte Geschlecht
X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- First U.S. commercial sales of XOLREMDI™ (mavorixafor) following April 2024 FDA approval
- Positive interim data…
MICSE guidelines published in “Cell” provide a universal toolset for cellular senescence in vivo research
Targeting cellular senescence as a therapeutic strategy is considered of great promise to address age-associated…
QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform
Austrian Research Promotion Agency FFG awards funding to QUANTRO, accelerating the next development phase of its…
AOP Health New Cancer Trial
A new therapeutic approach to fight cancer
MedUni Vienna: New method for diagnosing and monitoring COVID-19 severity
A research team led by MedUni Vienna has shown in a study that purely optical measurements of the viscosity of blood…
BMAW: Bundesminister Kocher: Förderprogramm „Laura Bassi“ für chancengerechtere Zukunft
Ausschreibung des Förderprogramms „Laura Bassi - Gestaltung einer chancengerechten Zukunft“ startet im Herbst 2024
MedUni Vienna: Heart failure in type 2 diabetes: Current diagnostic methods unreliable in women
A MedUni Vienna study has investigated gender-specific differences in the diagnosis of systolic heart failure in…